{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:46:27Z","timestamp":1769193987327,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jtct.2023.01.030","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T18:36:46Z","timestamp":1675535806000},"page":"289-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-798X","authenticated-orcid":false,"given":"Emily S.","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genovefa A.","family":"Papanicolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeet S.","family":"Dadwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-5196","authenticated-orcid":false,"given":"Steve","family":"Pergam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-6522","authenticated-orcid":false,"given":"Amy","family":"Spallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.01.030_bib0001","unstructured":"World Health Organization (WHO). Monkeypox fact sheet. May 19, 2022. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox. Accessed November 3, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001769","article-title":"Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus","volume":"20","author":"Happi","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jtct.2023.01.030_bib0003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3201\/eid2604.191164","article-title":"Human-to-human transmission of monkeypox virus, United Kingdom, October 2018","volume":"26","author":"Vaughan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0004","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.15585\/mmwr.mm7123e1","article-title":"Monkeypox outbreak\u2014nine states, May 2022","volume":"71","author":"Minhaj","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2023.01.030_bib0006","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmi.2022.08.012","article-title":"Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: an observational cohort study","volume":"29","author":"Mailhe","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jtct.2023.01.030_bib0007","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3201\/eid2810.221191","article-title":"Human monkeypox without viral prodrome or sexual exposure, California, USA, 2022","volume":"28","author":"Karan","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0008","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.15585\/mmwr.mm7134e1","article-title":"High-contact object and surface contamination in a household of persons with monkeypox virus infection\u2014Utah, June 2022","volume":"71","author":"Pfeiffer","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2023.01.030_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12941-022-00527-1","article-title":"Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis","volume":"21","author":"Benites-Zapata","year":"2022","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jtct.2023.01.030_bib0010","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries\u2014April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.01.030_bib0012","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.01.030_bib0013","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.15585\/mmwr.mm7132e3","article-title":"Epidemiologic and clinical characteristics of monkeypox cases\u2014United States, May 17-July 22, 2022","volume":"71","author":"Philpott","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2023.01.030_bib0014","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2023.01.030_bib0015","doi-asserted-by":"crossref","unstructured":"Su\u00f1er C, Ubals M, Tar\u00edn-Vicente EJ, et al. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain [e-pub ahead of print]. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00794-0. accessed January 17, 2023.","DOI":"10.1016\/S1473-3099(22)00794-0"},{"key":"10.1016\/j.jtct.2023.01.030_bib0016","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2023.01.030_bib0017","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3201\/eid2811.221215","article-title":"Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak","volume":"28","author":"Turner","year":"2022","journal-title":"Emerg Infect Dis J"},{"key":"10.1016\/j.jtct.2023.01.030_bib0018","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200421","article-title":"Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022","volume":"27","author":"Antinori","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jtct.2023.01.030_bib0019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1017\/ice.2022.152","article-title":"Monkeypox transmission following exposure in healthcare facilities in nonendemic settings: low risk but limited literature","volume":"43","author":"Zachary","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jtct.2023.01.030_bib0020","unstructured":"Centers for Disease Control and Prevention. Vaccination administration considerations for specific populations. Available at:https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/interim-considerations\/special-populations.html. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0021","unstructured":"Centers for Disease Control and Prevention. Monkeypox and smallpox vaccine guidance. Available at: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/smallpox-monkeypox.html. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0022","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001","volume":"206","author":"Lederman","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0023","unstructured":"Centers for Disease Control and Prevention. Monkeypox treatment information for healthcare professionals. Available at: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0024","unstructured":"Food and Drug Administration. Important information for human cell, tissue, and cellular and tissue-based product (HCT\/P) establishments regarding monkeypox virus and HCT\/P donation. Available at:https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/important-information-human-cell-tissue-and-cellular-and-tissue-based-product-hctp-establishments-0. Accessed September 15, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0025","unstructured":"Organ Procurement and Transplant Network (OPTN). Monkeypox and solid organ donation. August 4, 2022. Available at: https:\/\/optn.transplant.hrsa.gov\/news\/monkeypox-and-solid-organ-donation\/. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0026","unstructured":"Association for the Advancement of Blood and Biotherapies. Monkeypox resources to consider. August 31, 2022. Available at:https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/regulatory\/monkeypox-resources-to-consider.pdf?sfvrsn=40773b5e_6. Accessed January 17, 2023."},{"key":"10.1016\/j.jtct.2023.01.030_bib0027","unstructured":"National Marrow Donor Program. NMDP Form A00972: Monkeypox infection rationale and action guide. 2022. Available at: https:\/\/network.bethematchclinical.org\/transplant-centers\/forms\/. Accessed January 17, 2023."},{"key":"10.1016\/j.jtct.2023.01.030_bib0028","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1097\/TP.0000000000004337","article-title":"Monkeypox in transplant recipients: no breaks between outbreaks","volume":"106","author":"Al Jurdi","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.01.030_bib0029","unstructured":"Food and Drug Administration. Guidance for Industry: Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT\/Ps). August 2007. Available at:https:\/\/www.fda.gov\/files\/vaccines,%20blood%20&%20biologics\/published\/Eligibility-Determination-for-Donors-of-Human-Cells\u2013Tissues\u2013and-Cellular-and-Tissue-Based-Products\u2013Guidance-for-Industry.pdf. Accessed January 17, 2023."},{"key":"10.1016\/j.jtct.2023.01.030_bib0030","unstructured":"Centers for Disease Control and Prevention. Severe manifestations of monkeypox among people who are immunocompromised due to HIV or other conditions. September 29, 2022. Available at: https:\/\/emergency.cdc.gov\/han\/2022\/han00475.asp. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.01.030_bib0032","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.15585\/mmwr.mm7137e1","article-title":"Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol\u2014United States, May-August 2022","volume":"71","author":"O'Laughlin","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtct.2023.01.030_bib0033","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.01044-08","article-title":"In vitro efficacy of ST246 against smallpox and monkeypox","volume":"53","author":"Smith","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtct.2023.01.030_bib0034","unstructured":"SIGA Technologies. TPOXX (tecovirimat) fact sheet. 2020. Available at: https:\/\/www.siga.com\/wp-content\/themes\/sigahba\/TPOXX-Fact-Sheet.pdf. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0035","unstructured":"US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. STOMP study of tecovirimat for human monkeypox virus. 2022. Available at: https:\/\/www.stomptpoxx.org\/aboutTrial. Accessed November 2, 2022."},{"key":"10.1016\/j.jtct.2023.01.030_bib0036","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.01.030_bib0037","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2023.01.030_bib0038","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2015.06.075","article-title":"Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects","volume":"33","author":"Frey","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jtct.2023.01.030_bib0039","unstructured":"Food and Drug Administration. ACAM2000 package insert. 2007. Available at: https:\/\/www.fda.gov\/files\/vaccines\/2C\/20blood\/20\/26\/20biologics\/published\/Package-Insert\u2013ACAM2000.pdf. Accessed January 17, 2023."},{"key":"10.1016\/j.jtct.2023.01.030_bib0040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.15585\/mmwr.mm7138e2","article-title":"Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients\u2014Colorado, 2022","volume":"71","author":"Marshall","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723010679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723010679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:07:36Z","timestamp":1763003256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723010679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2666636723010679"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.030","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}